Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04264949
Other study ID # RBHP 2019 LECHAUVE
Secondary ID 2019-A02191-56
Status Completed
Phase N/A
First received
Last updated
Start date March 9, 2020
Est. completion date December 18, 2023

Study information

Verified date February 2024
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective is to assess the impact of smartphone application on adherence to a physical exercise program in chronic low back pain patients. Adherence to a physical exercise program will be assessed at the start of the protocol, at three weeks and six months. A control group will benefit from conventional care in a rehabilitation center and an intervention group will benefit from a conventional care in a rehabilitation center accompanied by education in the use of a smartphone application including physical exercises and information about low back pain. The hypothesis of the search is that adherence is better in intervention group than control group at 6 months due to education in the use of smartphone application.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 18, 2023
Est. primary completion date December 18, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult People - With nonspecific chronic low back pain (according to the definition of the HAS) - Covered under the national health insurance - Giving informed written consent to participate in the study Exclusion Criteria: - Patient who do not meet the diagnostic criteria according to the definition of HAS - Behavioral disorders or comprehension difficulties making assessment impossible - Patient with a contraindication to physical exercise for medical reasons - Patient under guardianship, curatorship or safeguard of justice

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Education in the use of smartphone app (Mon coach dos)
In addition to conventional care and the therapeutic education program, GA will benefit from three education sessions (one per week) on the use of the smartphone app mon coach dos
conventional care
conventional care and the therapeutic education program

Locations

Country Name City State
France Chu Clermont Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary EARS : exercise adherence rating scale EARS assess the adherence in physical activity program. day1
Primary EARS : exercise adherence rating scale EARS assess the adherence in physical activity program. day 15
Primary EARS : exercise adherence rating scale EARS assess the adherence in physical activity program. day 180
Secondary OSWESTRY questionnaire Disability is measured by OSWESTRY day1, day 15, day 180
Secondary EPAP questionnaire The perceived barriers to and facilitators of physical activity are measured by EPAP day1, day 15, day 180
Secondary Pain measurment: numeric scale The pain is measured by numeric scale day1, day 15, day 180
Secondary 6 minutes' walk test (6MWT) Aerobic and functional capacities are measured by 6 minutes' walk test (6MWT) day1, day 15, day 180
Secondary aerobic capacities aerobic capacities are measured by sub maximal ergocycle test day1, day 15, day 180
Secondary muscular endurance the muscular endurance of the erector muscles of the spine is measured by Sorensen test day1, day 15, day 180
Secondary muscular endurance of the flexor muscles of the spine the muscular endurance of the flexor muscles of the spine is measured by ITO test day1, day 15, day 180
Secondary muscular endurance of the extensor of the knee the muscular endurance of the extensor of the knee is measured by Killy test day1, day 15, day 180
Secondary Core measurment Core is measured by plank test day1, day 15, day 180
Secondary Flexibility on posterior chain Flexibility on posterior chain is measured by DDS test day1, day 15, day 180
Secondary Mobility on posterior chain Mobility on posterior chain is measured by Schober test day1, day 15, day 180
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3